Amarin Corporation PLC Company Profile (NASDAQ:AMRN)

About Amarin Corporation PLC (NASDAQ:AMRN)

Amarin Corporation PLC logoAmarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AMRN
  • CUSIP: N/A
  • Web: www.amarincorp.com
Capitalization:
  • Market Cap: $890.91 million
  • Outstanding Shares: 270,792,000
Average Prices:
  • 50 Day Moving Avg: $3.25
  • 200 Day Moving Avg: $3.30
  • 52 Week Range: $2.64 - $4.47
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 329.00
  • P/E Growth: -1.71
Sales & Book Value:
  • Annual Revenue: $151.31 million
  • Price / Sales: 5.89
  • Book Value: ($0.23) per share
  • Price / Book: -14.30
Profitability:
  • EBIDTA: ($57,340,000.00)
  • Net Margins: -51.42%
  • Return on Assets: -39.14%
Debt:
  • Debt-to-Equity Ratio: -1.71%
  • Current Ratio: 1.74%
  • Quick Ratio: 1.46%
Misc:
  • Average Volume: 2.67 million shs.
  • Beta: 0.68
  • Short Ratio: 2.62
 

Frequently Asked Questions for Amarin Corporation PLC (NASDAQ:AMRN)

What is Amarin Corporation PLC's stock symbol?

Amarin Corporation PLC trades on the NASDAQ under the ticker symbol "AMRN."

How were Amarin Corporation PLC's earnings last quarter?

Amarin Corporation PLC (NASDAQ:AMRN) posted its earnings results on Wednesday, August, 2nd. The company reported ($0.05) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.06) by $0.01. The company earned $44.95 million during the quarter, compared to analysts' expectations of $40.35 million. The company's revenue for the quarter was up 37.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.07) earnings per share. View Amarin Corporation PLC's Earnings History.

When will Amarin Corporation PLC make its next earnings announcement?

Amarin Corporation PLC is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Amarin Corporation PLC.

Where is Amarin Corporation PLC's stock going? Where will Amarin Corporation PLC's stock price be in 2017?

4 analysts have issued 1 year price targets for Amarin Corporation PLC's shares. Their predictions range from $5.00 to $10.00. On average, they expect Amarin Corporation PLC's share price to reach $8.00 in the next year. View Analyst Ratings for Amarin Corporation PLC.

What are analysts saying about Amarin Corporation PLC stock?

Here are some recent quotes from research analysts about Amarin Corporation PLC stock:

  • 1. Cantor Fitzgerald analysts commented, "At ESC, Novartis released data from its Phase 3 CANTOS study for ACZ885." (8/29/2017)
  • 2. According to Zacks Investment Research, "Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies. " (8/7/2017)

Who are some of Amarin Corporation PLC's key competitors?

Who are Amarin Corporation PLC's key executives?

Amarin Corporation PLC's management team includes the folowing people:

  • Lars G. Ekman M.D., Ph.D., Independent Chairman of the Board
  • John F. Thero CPA, President, Chief Executive Officer, Assistant Secretary, Director
  • Michael Wayne Kalb CPA, Chief Financial Officer, Senior Vice President
  • Stephen B. Ketchum Ph.D., President - Research and Development, Senior Vice President, Chief Scientific Officer
  • Joseph T. Kennedy J.D., Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
  • Aaron D. Berg, Senior Vice President - Marketing and Sales
  • Michael J. Farrell, Vice President - Finance (principal accounting officer and principal financial officer)
  • Craig B. Granowitz M.D., Ph.D., Chief Medical Officer
  • Joseph S. Zakrzewski, Director
  • Patrick J. O'Sullivan, Non-Executive Independent Director

Who owns Amarin Corporation PLC stock?

Amarin Corporation PLC's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Balyasny Asset Management LLC (1.06%), Broadfin Capital LLC (0.94%), FMR LLC (0.75%), Farallon Capital Management LLC (0.55%), California Public Employees Retirement System (0.17%) and Healthcare Value Capital LLC (0.17%). Company insiders that own Amarin Corporation PLC stock include John F Thero and Joseph T Kennedy. View Institutional Ownership Trends for Amarin Corporation PLC.

Who sold Amarin Corporation PLC stock? Who is selling Amarin Corporation PLC stock?

Amarin Corporation PLC's stock was sold by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Broadfin Capital LLC, California Public Employees Retirement System, Ameriprise Financial Inc., Northern Trust Corp, ProShare Advisors LLC, Sterling Capital Management LLC and Private Advisor Group LLC. View Insider Buying and Selling for Amarin Corporation PLC.

Who bought Amarin Corporation PLC stock? Who is buying Amarin Corporation PLC stock?

Amarin Corporation PLC's stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., GSA Capital Partners LLP, Intrinsic Edge Capital Management LLC, Stonepine Capital Management LLC, OxFORD Asset Management LLP, Airain ltd, Dynamic Technology Lab Private Ltd and Perkins Capital Management Inc.. View Insider Buying and Selling for Amarin Corporation PLC.

How do I buy Amarin Corporation PLC stock?

Shares of Amarin Corporation PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amarin Corporation PLC's stock price today?

One share of Amarin Corporation PLC stock can currently be purchased for approximately $3.29.


MarketBeat Community Rating for Amarin Corporation PLC (NASDAQ AMRN)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  374 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  580
MarketBeat's community ratings are surveys of what our community members think about Amarin Corporation PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Amarin Corporation PLC (NASDAQ:AMRN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (143.16% upside)

Analysts' Ratings History for Amarin Corporation PLC (NASDAQ:AMRN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/14/2017Cantor FitzgeraldReiterated RatingBuy$10.00HighView Rating Details
8/9/2017HC WainwrightReiterated RatingBuy$10.00MediumView Rating Details
8/3/2017Jefferies Group LLCReiterated RatingBuy$7.00MediumView Rating Details
10/19/2016Citigroup Inc.Initiated CoverageBuy$5.00N/AView Rating Details
(Data available from 9/24/2015 forward)

Earnings

Earnings History for Amarin Corporation PLC (NASDAQ:AMRN)
Earnings by Quarter for Amarin Corporation PLC (NASDAQ:AMRN)
Earnings History by Quarter for Amarin Corporation PLC (NASDAQ AMRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017        
8/2/20176/30/2017($0.06)($0.05)$40.35 million$44.95 millionViewListenView Earnings Details
5/4/20173/31/2017($0.07)($0.08)$37.85 million$34.60 millionViewListenView Earnings Details
2/28/201712/31/2016($0.09)($0.05)$36.13 million$38.40 millionViewListenView Earnings Details
11/3/2016Q316($0.10)($0.08)$32.03 million$32.40 millionViewN/AView Earnings Details
8/4/2016Q216($0.13)($0.07)$29.97 million$32.82 millionViewN/AView Earnings Details
5/5/2016Q116($0.11)($0.14)$26.77 million$25.30 millionViewN/AView Earnings Details
2/25/2016Q415($0.08)($0.12)$23.62 million$26.40 millionViewListenView Earnings Details
11/4/2015Q315($0.12)($0.18)$21.93 million$21.30 millionViewN/AView Earnings Details
8/6/2015Q2($0.12)($0.15)$19.10 million$17.70 millionViewN/AView Earnings Details
5/8/2015Q115($0.11)($0.18)$21.86 million$15.60 millionViewN/AView Earnings Details
3/3/2015Q414($0.13)($0.11)$17.40 million$16.50 millionViewN/AView Earnings Details
11/6/2014Q314($0.14)($0.18)$14.87 million$14.15 millionViewN/AView Earnings Details
8/7/2014Q214($0.15)($0.14)$12.86 million$12.60 millionViewN/AView Earnings Details
5/9/2014Q114($0.18)($0.17)$11.65 million$11.00 millionViewN/AView Earnings Details
2/27/2014Q413($0.23)($0.26)$11.17 million$10.10 millionViewN/AView Earnings Details
11/7/2013($0.32)($0.25)$10.25 million$8.40 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.38)($0.26)$5.50 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.39)($0.41)$5.21 million$2.34 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.28)($0.28)ViewN/AView Earnings Details
11/8/2012Q312($0.22)($0.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amarin Corporation PLC (NASDAQ:AMRN)
2017 EPS Consensus Estimate: ($0.23)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.07)($0.06)($0.07)
Q2 20172($0.06)($0.06)($0.06)
Q3 20172($0.06)($0.05)($0.06)
Q4 20172($0.05)($0.04)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Amarin Corporation PLC (NASDAQ:AMRN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Amarin Corporation PLC (NASDAQ:AMRN)
Insider Ownership Percentage: 3.72%
Institutional Ownership Percentage: 37.76%
Insider Trades by Quarter for Amarin Corporation PLC (NASDAQ:AMRN)
Institutional Ownership by Quarter for Amarin Corporation PLC (NASDAQ:AMRN)
Insider Trades by Quarter for Amarin Corporation PLC (NASDAQ:AMRN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/3/2017Joseph T. KennedyGeneral CounselSell307,911$4.00$1,231,644.00View SEC Filing  
2/1/2016John F TheroCEOBuy25,000$1.37$34,250.00View SEC Filing  
8/11/2015John F TheroCEOBuy20,000$2.35$47,000.00View SEC Filing  
11/12/2014John F TheroInsiderBuy50,000$0.83$41,500.00View SEC Filing  
11/11/2014Michael James FarrellInsiderBuy5,500$0.84$4,620.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Amarin Corporation PLC (NASDAQ:AMRN)
Latest Headlines for Amarin Corporation PLC (NASDAQ:AMRN)
Source:
DateHeadline
americanbankingnews.com logoComparing Neurocrine Biosciences (NBIX) and Amarin Corporation PLC (AMRN)
www.americanbankingnews.com - September 22 at 9:02 AM
globenewswire.com logoAmarin to Present at Cantor Global Healthcare Conference - GlobeNewswire (press release)
www.globenewswire.com - September 20 at 9:03 PM
feeds.benzinga.com logoAmarin to Present at Cantor Global Healthcare Conference
feeds.benzinga.com - September 20 at 5:16 PM
americanbankingnews.com logo$45.10 Million in Sales Expected for Amarin Corporation PLC (AMRN) This Quarter
www.americanbankingnews.com - September 20 at 9:22 AM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Receives Overweight Rating from Cantor Fitzgerald
www.americanbankingnews.com - September 14 at 12:28 PM
seekingalpha.com logoAmarin (AMRN) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 14 at 3:05 AM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - September 13 at 8:54 PM
finance.yahoo.com logoAmarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
finance.yahoo.com - September 13 at 5:00 PM
finance.yahoo.com logoETFs with exposure to Amarin Corp. Plc : September 12, 2017
finance.yahoo.com - September 12 at 1:17 AM
seekingalpha.com logoAmarin: REDUCE-IT Continues On To Conclusion - Seeking Alpha
seekingalpha.com - September 9 at 3:40 PM
finance.yahoo.com logoAmarin to Present at Rodman & Renshaw’s Global Investment Conference
finance.yahoo.com - September 6 at 3:45 PM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Expected to Announce Quarterly Sales of $45.10 Million
www.americanbankingnews.com - September 1 at 1:34 AM
finance.yahoo.com logoETFs with exposure to Amarin Corp. Plc : August 31, 2017
finance.yahoo.com - September 1 at 1:14 AM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - August 29 at 1:04 PM
americanbankingnews.com logoBidaskClub Downgrades Amarin Corporation PLC (AMRN) to Strong Sell
www.americanbankingnews.com - August 27 at 11:02 PM
finance.yahoo.com logoAmarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 5:26 PM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 19 at 6:50 PM
seekingalpha.com logoThe Fish Market: What Is Amarin Worth? - Seeking Alpha
seekingalpha.com - August 14 at 9:17 PM
streetinsider.com logoAmarin (AMRN) Says REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at ... - StreetInsider.com
www.streetinsider.com - August 14 at 4:11 PM
finance.yahoo.com logoAmarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee
finance.yahoo.com - August 14 at 4:11 PM
finance.yahoo.com logoFeatured Company News – GlaxoSmithKline Drops Options to Licence Inotersen and IONIS-FB-LRx; Ionis Pharma to Continue Development Independently
finance.yahoo.com - August 14 at 4:11 PM
americanbankingnews.com logoAmarin Corporation PLC (NASDAQ:AMRN) PT Set at $10.00 by Cantor Fitzgerald
www.americanbankingnews.com - August 14 at 11:40 AM
americanbankingnews.com logoZacks: Analysts Expect Amarin Corporation PLC (NASDAQ:AMRN) Will Announce Quarterly Sales of $45.10 Million
www.americanbankingnews.com - August 14 at 5:46 AM
americanbankingnews.com logoBidaskClub Lowers Amarin Corporation PLC (NASDAQ:AMRN) to Sell
www.americanbankingnews.com - August 13 at 2:38 PM
americanbankingnews.com logoZacks: Brokerages Expect Amarin Corporation PLC (NASDAQ:AMRN) to Post -$0.05 EPS
www.americanbankingnews.com - August 12 at 2:26 PM
americanbankingnews.com logoFY2017 Earnings Forecast for Amarin Corporation PLC Issued By Cantor Fitzgerald (NASDAQ:AMRN)
www.americanbankingnews.com - August 10 at 1:50 PM
seekingalpha.com logoAmarin And REDUCE-IT: The Second Interim Analysis - Seeking Alpha
seekingalpha.com - August 8 at 3:42 PM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Downgraded by Zacks Investment Research
www.americanbankingnews.com - August 7 at 9:56 PM
americanbankingnews.com logoFY2018 EPS Estimates for Amarin Corporation PLC Cut by SunTrust Banks (NASDAQ:AMRN)
www.americanbankingnews.com - August 7 at 9:30 AM
americanbankingnews.com logoAmarin Corporation PLC (NASDAQ:AMRN) to Post FY2017 Earnings of ($0.23) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - August 7 at 8:09 AM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - August 5 at 9:56 PM
americanbankingnews.com logoFY2021 EPS Estimates for Amarin Corporation PLC Boosted by Analyst (AMRN)
www.americanbankingnews.com - August 4 at 8:00 PM
finance.yahoo.com logoEdited Transcript of AMRN earnings conference call or presentation 2-Aug-17 12:00pm GMT
finance.yahoo.com - August 4 at 4:12 PM
finance.yahoo.com logoAre Options Traders Betting on a Big Move in Amarin (AMRN) Stock?
finance.yahoo.com - August 4 at 4:11 PM
seekingalpha.com logoAmarin Increases Its Revenue Guidance For 2017 - Seeking Alpha
seekingalpha.com - August 3 at 5:18 PM
seekingalpha.com logoAmarin Increases Its Revenue Guidance For 2017 - Seeking Alpha
seekingalpha.com - August 3 at 5:18 PM
finance.yahoo.com logoAmarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations
finance.yahoo.com - August 2 at 3:45 PM
finance.yahoo.com logoInvestor Network: Amarin Corporation Plc to Host Earnings Call
finance.yahoo.com - August 2 at 3:45 PM
finance.yahoo.com logoHere's Why Amarin Corporation plc Is on the Rise Today
finance.yahoo.com - August 2 at 3:45 PM
finance.yahoo.com logoAmarin reports 2Q loss
finance.yahoo.com - August 2 at 3:45 PM
americanbankingnews.com logoAmarin Corporation PLC (NASDAQ:AMRN) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - August 2 at 2:24 PM
fool.com logoHere's Why Amarin Corporation plc Is on the Rise Today
www.fool.com - August 2 at 1:53 PM
seekingalpha.com logoIs Amarin A Good Catch? - Seeking Alpha
seekingalpha.com - August 1 at 4:49 PM
finance.yahoo.com logoInvestor Calendar Invites You to the Amarin Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017
finance.yahoo.com - August 1 at 4:49 PM
americanbankingnews.com logoAmarin Corporation PLC (NASDAQ:AMRN) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - July 29 at 9:52 PM
globenewswire.com logoAmarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 - GlobeNewswire (press release)
www.globenewswire.com - July 27 at 3:32 PM
nasdaq.com logoAmarin to Report Second Quarter 2017 Results and Host ... - Nasdaq - Nasdaq
www.nasdaq.com - July 27 at 3:32 PM
seekingalpha.com logoA Look At Amarin At $4 - Seeking Alpha
seekingalpha.com - July 27 at 3:32 PM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Expected to Announce Quarterly Sales of $41.37 Million
www.americanbankingnews.com - July 27 at 1:36 PM
americanbankingnews.com logoAmarin Corporation PLC (AMRN) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - July 27 at 10:07 AM

Social

Chart

Amarin Corporation PLC (AMRN) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff